enow.com Web Search

  1. Ads

    related to: acute lymphoblastic leukemia treatment plan options

Search results

  1. Results from the WOW.Com Content Network
  2. Acute lymphoblastic leukemia - Wikipedia

    en.wikipedia.org/wiki/Acute_lymphoblastic_leukemia

    Brexucabtagene autoleucel (Tecartus) was approved for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia in October 2021. [ 71 ] [ 72 ] Each dose of brexucabtagene autoleucel is a customized treatment created using the recipient's own immune system to help fight the lymphoma. [ 73 ]

  3. Obecabtagene autoleucel - Wikipedia

    en.wikipedia.org/wiki/Obecabtagene_autoleucel

    Obecabtagene autoleucel, sold under the brand name Aucatzyl, is an anti-cancer medication used for the treatment of acute lymphoblastic leukemia. [1] [2] It is a CD19-directed genetically modified autologous T-cell immunotherapy.

  4. Tisagenlecleucel - Wikipedia

    en.wikipedia.org/wiki/Tisagenlecleucel

    Tisagenlecleucel is indicated for the treatment of those under 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse; or adults with relapsed or refractory (r/r) large B-cell lymphoma after two or more lines of systemic therapy including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, high grade B-cell lymphoma ...

  5. Blinatumomab - Wikipedia

    en.wikipedia.org/wiki/Blinatumomab

    In July 2014, the FDA granted breakthrough therapy status to blinatumomab for the treatment of acute lymphoblastic leukemia (ALL). [12] In October 2014, Amgen's Biologics License Application for blinatumomab was granted priority review designation by the FDA, thus establishing a deadline of 19 May 2015, for completion of the FDA review process ...

  6. Acute lymphoblastic leukemia (ALL) 4.0% Acute myeloid leukemia (AML) 8.7% Chronic lymphocytic leukemia (CLL) sorted under lymphomas according to current WHO classification; called small lymphocytic lymphoma (SLL) when leukemic cells are absent. 10.2% Chronic myelogenous leukemia (CML) 3.7% Acute monocytic leukemia (AMoL) 0.7% Other leukemias 3.1%

  7. He was just a toddler when he began difficult leukemia ... - AOL

    www.aol.com/just-toddler-began-difficult...

    In 2019, he was diagnosed at Joe DiMaggio Children’s Hospital in Hollywood with high-risk lymphoblastic leukemia. Ever since then, she’s been by his side. “He is a boy who has adapted a lot ...

  1. Ads

    related to: acute lymphoblastic leukemia treatment plan options